Diagnostic agent for hypoxia or mitochondrial dysfunction compri

Details Diagnostic agent for hypoxia or mitochondrial dysfunction compri Diagnostic agent for hypoxia or mitochondrial dysfunction compri

1996-01-11

1998-12-01

Kight, John

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

In an organic compound

564 36, 564 19, 424 111, A61K 5100, A61M 3614

Patent

active

058434003

ABSTRACT:
A diagnostic agent for hypoxia or mitochondrial dysfunction is disclosed, comprising a radioactive copper complex of a dithiosemicarbazone derivative or a radioactive copper complex of a diamine diol schiff base derivative. This agent has good transferability to the target tissue, reduction reaction affinity at a hypoxic site, high stability in a non-target site and rapidly disappears.

REFERENCES:
patent: 4795626 (1989-01-01), Deutsch et al.
patent: 4915931 (1990-04-01), Yokoyama et al.
patent: 4917879 (1990-04-01), Deutsch et al.
patent: 5071636 (1991-12-01), Yamauchi et al.
patent: 5079346 (1992-01-01), Kung
Mathias et al (Aug. 1995), J. Nucl. Med, vol. 36, No. 8, pp. 1451-1455, "Species-Dependent Binding of Copper (II) Bis(Thiosemicarbazone) Radiopharmaceuticals to Serum Albumin".
Pastakia et al (1980), J. Nucl. Med, vol. 21, No. 1, pp. 67-70, "Tissue Distribution of Copper Labeled 3-ethoxy-2-oxobutyraldehyde bis (thiosemicarbazone) (Cu-64KTS) in Mice and Rats: Concise Communication".
Kagwanja et al (1994). Polyhedron, vol. 13, No. 18, pp. 2615-2627 Formation of Trimetallic Complexes Containing Redox-Active Nitrosyl Molybdenum Tris (3,5-dimethylpyrazolyl)-borato groups.
Green (1987), Nucl. Med. Biol., vol. 14, No. 1, pp. 59-61, "A Potential Copper Radiopharmaceutical for Imaging the Heart and Brain: Copper-Labeled Pyruvaldehyde Bis (N.sup.4 -methylthiosemicarbazone".
John et al (1994). Journal of Pharmaceutical Sciences, vol. 83, No. 4, pp. 587-590,"Preparation and Biodstribution of Copper-67 Complexes with Tetradentate Schiff-Base Ligands".
Deutsch et al (1987), J. Nucl. Med., vol. 28, No. 12, pp. 1870-1880, Development of Non-reducible Technetium-99m (III) cations as Myocardial Perfusion Imaging Agents: Initial Experience in Humans.
Geison et al (1994), J. Nucl. Med., vol. 35, No. 10., pp. 1698-1706, "Myocardial Uptake and Kinetic Properties of Technetium-99m-Q3 in Dogs".
Taniuchi et al (1995), Biol. Pharm. Bull., Vol. 18, No. 8, pp. 1126-1129, Cu-Pyruvaldehyde-bis (N.sup.4 -methylthiosemicarbazone) (Cu-PTSM), a Metal Complex with Selective NADH-Dependent Reduction by Complex I in Brain Mitochondria: A Potential Radiopharmaceutical for Mitochondria-Functional Imaging with Positron Emission Tomography.
John et al (1990), J. Med. Chem, vol. 33, No. 6, pp. 1764-1770, Structure Activity Relationships for Metal Labeled Blood Flow Tracers: Comparison of Keto Aldehyde Bis(thiosemicarbazonato) Copper II Derivatives.
Fujibayashi, et al (1993), Biol. Pharm. Bull., vol. 16, No. 2, pp. 146-149 "Mitochondria Selective Reduction of .sup.62 Cu -Pyruvaldehyde Bis (N.sup.4 -methylthiosemicarbazone) (.sup.62 Cu-PTSM) in the Murine Brain; a Novel Radiopharmaceutical for Brain Positron Emission Tomography (PET) Imaging".
K. Wada et al., "CU-ATSM, an Intracellular-Accessible Superoxide Dismutase (SOD)-Like Copper Complex: Evaluation in an Ischemia-Reperfusion Injury Model", Biol. Pharm. Bull., vol. 17, No. 5, May 1994, pp. 701-704.
K. Wada et al., "Effects of Ischemia-reperfusion Injury on Myocardial Single Pass Extraction and Retention of CU-PTSM in Perfused Rat Hearts: Comparison with .sup.201 Tl and .sup.14 C-Iodoantipyrine", Nucl. Med. Biol., vol. 21, No. 4, 1994, pp. 613-617.
E.K. John et al., "Preparation and Biodistribution of Copper-67 Complexes with Tetradentate Schiff-Base Ligands", Journal of Pharmaceutical Sciences, vol. 83, No. 4, Apr. 1994, pp. 587-590.
Journal of Nuclear Medicine, New York, NY, US, vol. 29, No. 9, Sep. 1988, pp. 1549-1557, Green, M.A. et al: "Copper (II) Bis(Thiosemicarbazone) Complexes as Potential Tracers for Evaluation of Cerebral and Myocardial Blood Flow with Pet".
Journal of Medicinal Chemistry, vol. 33, 1990, Washington US, pp. 1764-1770, E.K. John et al,: "Structure-Activity Relationships for Metal-Labeled Blood Flow Tracers: Comparision of Keto Aldehyde Bis(Thiosemicarbazonato)Copper(II) Derivatives".
Chemical Abstracts, vol. 119, No. 19, 8 Nov. 1993, Columbus, Ohio, US; abstract No. 198662, Yokoyama, A. et al: "Basic research on the development of radioactive-copper labeled radiopharmaceuticals" *abstract* Coden: KDGHDH;ISSN: 0287-9808, 1992.
Journal of Nuclear Medicine, vol. 36, No. 5, May 1995, New York US, p. 49P, Y. Yonekura et al: "New Nonnitroimidazole Hypoxia Imaging Agents, CU-62-Dithiosemicarbazone Complexs with Low Redoxpotential"(abstract No. 197).

Affiliated with

Also associated with

Rating

Diagnostic agent for hypoxia or mitochondrial dysfunction compri does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnostic agent for hypoxia or mitochondrial dysfunction compri, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic agent for hypoxia or mitochondrial dysfunction compri will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2393199